日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort

自身免疫性淋巴增生综合征的肺部表现:一项针对特殊患者群体的回顾性研究

Lau, Chuen-Yen; Mihalek, Andrew D; Wang, Jing; Dodd, Lori E; Perkins, Katie; Price, Susan; Webster, Sharon; Pittaluga, Stefania; Folio, Les R; Rao, V Koneti; Olivier, Kenneth N

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.

利用生物标志物预测具有自身免疫性淋巴增生综合征特征的患者中是否存在 FAS 突变

Caminha Iusta, Fleisher Thomas A, Hornung Ronald L, Dale Janet K, Niemela Julie E, Price Susan, Davis Joie, Perkins Katie, Dowdell Kennichi C, Brown Margaret R, Rao V Koneti, Oliveira João Bosco

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)

利妥昔单抗用于治疗自身免疫性淋巴增生综合征(ALPS)相关的难治性血细胞减少症

Rao, V Koneti; Price, Susan; Perkins, Katie; Aldridge, Patricia; Tretler, Jean; Davis, Joie; Dale, Janet K; Gill, Fred; Hartman, Kip R; Stork, Linda C; Gnarra, David J; Krishnamurti, Lakshmanan; Newburger, Peter E; Puck, Jennifer; Fleisher, Thomas